{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:45:38Z","timestamp":1776908738476,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40259-017-0238-1","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T06:42:09Z","timestamp":1501137729000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Patients\u2019 Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey"],"prefix":"10.1007","volume":"31","author":[{"given":"Mohammed I.","family":"Aladul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-7742","authenticated-orcid":false,"given":"Stephen R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"1","key":"238_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","volume":"7","author":"F Salaffi","year":"2009","unstructured":"Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. 2009;7(1):25.","journal-title":"Health Qual Life Outcomes"},{"issue":"9602","key":"238_CR2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861\u201374.","journal-title":"Lancet"},{"issue":"1","key":"238_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/art.24367","volume":"61","author":"SM Kooij Van der","year":"2009","unstructured":"Van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Ewals JA, Han KH, Hazes JM, Kerstens PJ, Peeters AJ, van Zeben D, Breedveld FC, Huizinga TW, Dijkmans BA, Allaart CF. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis. Arthritis Care Res. 2009;61(1):4\u201312. doi:\n                        10.1002\/art.24367\n                        \n                    .","journal-title":"Arthritis Care Res"},{"key":"238_CR4","unstructured":"Health and Social Care Information Centre. Prescribing Costs in Hospitals and the Community England 2014\u201315. 2015. \n                        http:\/\/content.digital.nhs.uk\/catalogue\/PUB18973\/hosp-pres-eng-201415-report.pdf\n                        \n                    . Accessed 30 May 2017."},{"issue":"2","key":"238_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00296-014-3080-5","volume":"35","author":"VF Azevedo","year":"2015","unstructured":"Azevedo VF, Galli N, Kleinfelder A, D\u2019Ippolito J, Urbano PC. Etanercept biosimilars. Rheumatol Int. 2015;35(2):197\u2013209.","journal-title":"Rheumatol Int"},{"key":"238_CR6","unstructured":"European Medicine Agency. European public assessment reports. 2017. \n                        http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/landing\/epar_search.jsp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&keyword=Enter%20keywords&searchType=name&alreadyLoaded=true&status=Authorised&jsenabled=false&searchGenericType=biosimilars&orderBy=authDate&pageNo=1\n                        \n                    . Accessed 8 June 2017."},{"key":"238_CR7","doi-asserted-by":"publisher","first-page":"A10","DOI":"10.1136\/ejhpharm-2017-000640.23","volume":"24","author":"M Aladul","year":"2017","unstructured":"Aladul M, Fitzpatrick R, Chapman S. CP-024 factors affecting uptake of biosimilars. Eur J Hosp Pharm. 2017;24:A10\u20131. doi:\n                        10.1136\/ejhpharm-2017-000640.23\n                        \n                    .","journal-title":"Eur J Hosp Pharm"},{"key":"238_CR8","unstructured":"IMS Institute. Delivering on the potential of biosimilar medicines: the role of functioning competitive markets. 2016. \n                        http:\/\/www.imshealth.com\/files\/web\/IMSH%20Institute\/Healthcare%20Briefs\/Documents\/IMS_Institute_Biosimilar_Brief_March_2016.pdf\n                        \n                    . Accessed 11 July 2017."},{"key":"238_CR9","doi-asserted-by":"publisher","first-page":"e016730","DOI":"10.1136\/bmjopen-2017-016730","volume":"7","author":"SR Chapman","year":"2017","unstructured":"Chapman SR, Fitzpatrick RW, Aladul MI. Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey. BMJ Open. 2017;7:e016730. doi:\n                        10.1136\/bmjopen-2017-016730\n                        \n                    .","journal-title":"BMJ Open"},{"issue":"1","key":"238_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2474-15-333","volume":"15","author":"I Nota","year":"2014","unstructured":"Nota I, Drossaert CH, Taal E, Vonkeman HE, van de Laar MA. Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord. 2014;15(1):333.","journal-title":"BMC Musculoskelet Disord"},{"key":"238_CR11","unstructured":"NHS England. What is a biosimilar medicine? 2015. \n                        https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2015\/09\/biosimilar-guide.pdf\n                        \n                    . Accessed 30 May 2017."},{"key":"238_CR12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2147\/PPA.S104891","volume":"10","author":"I Jacobs","year":"2016","unstructured":"Jacobs I, Singh E, Sewell KL, AL-Sabbagh A, Shane LG. Patient attitudes and understanding about biosimilars: an international cross-sectional survey. Patient Prefer Adherence. 2016;10:937.","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"238_CR13","doi-asserted-by":"crossref","first-page":"e0175826","DOI":"10.1371\/journal.pone.0175826","volume":"12","author":"E Sullivan","year":"2017","unstructured":"Sullivan E, Piercy J, Waller J, Black CM, Kachroo S. Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn\u2019s disease across Germany. PloS One. 2017;12(4):e0175826.","journal-title":"PloS One"},{"key":"238_CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/PPA.S129333","volume":"11","author":"J Waller","year":"2017","unstructured":"Waller J, Sullivan E, Piercy J, Black CM, Kachroo S. Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany. Patient Prefer Adherence. 2017;11:519.","journal-title":"Patient Prefer Adherence"},{"key":"238_CR15","unstructured":"PMLiVE. Brand leaders in RA will lose market share, predict rheumatologists. 2013. \n                        http:\/\/www.pmlive.com\/pmhub\/healthcare_market_research\/109066_the_research_partnership\/white_papers_and_resources\/brand_leaders_in_ra_will_lose_market_share,_predict_rheumatologists\n                        \n                    . Accessed 4 April 2017."},{"key":"238_CR16","first-page":"10","volume-title":"Patient education: a practical approach","author":"BA Lyons","year":"2011","unstructured":"Lyons BA. Selecting and evaluating sources of patient education materials. In: Muma RD, Lyons BA, editors. Patient education: a practical approach. Massachusetts, Burlington: Jones & Bartlett Publishers; 2011. p. 10\u20134."},{"issue":"1","key":"238_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ecco-jcc\/jjw138","volume":"11","author":"L Peyrin-Biroulet","year":"2017","unstructured":"Peyrin-Biroulet L, L\u00f6nnfors S, Roblin X, Danese S, Avedano L. Patient perspectives on biosimilars: a survey by the European Federation of Crohn\u2019s and Ulcerative Colitis Associations. J Crohn\u2019s Colitis. 2017;11(1):128\u201333.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"238_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12916-015-0415-3","volume":"13","author":"SS Dunne","year":"2015","unstructured":"Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13(1):173.","journal-title":"BMC Med"},{"key":"238_CR19","unstructured":"The British Society of Rheumatology. British Society for Rheumatology Position statement on biosimilar medicines (Revised January 2017). 2017. \n                        http:\/\/www.nras.org.uk\/data\/files\/revised_bsr_biosimilars_position_statement_jan_2017.pdf\n                        \n                    . Accessed 1 June 2017."}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-017-0238-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-017-0238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-017-0238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T02:08:12Z","timestamp":1506046092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-017-0238-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1007\/s40259-017-0238-1","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}